NASDAQ : MMSI
Merit Medical Systems, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 93.39 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.58B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.17B |
| Enterprise Value | 5.49B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 59.92M |
| Shares Outstanding | 59.92M |
| Shares Change (YoY) | -0.82% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 2.31% |
| Owned by Institutions (%) | 106.29% |
| Float | 58.51M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 32.29 |
| Forward PE | 19.19 |
| PS Ratio | 3.21 |
| Forward PS | 3.02 |
| PB Ratio | 2.96 |
| P/TBV Ratio | 8.39 |
| P/FCF Ratio | 25.38 |
| P/OCF Ratio | 18.88 |
| PEG Ratio | 1.31 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 34.26 |
| EV / Sales | 3.41 |
| EV / EBITDA | 15.42 |
| EV / EBIT | 23.77 |
| EV / FCF | 26.94 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.52 |
| Quick Ratio | 2.90 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 2.20 |
| Debt / FCF | 4.04 |
| Interest Coverage | 7.13 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 9.78% |
| Return on Assets (ROA) | 5.19% |
| Return on Invested Capital (ROIC) | 8.48% |
| Return on Capital Employed (ROCE) | 8.67% |
| Weighted Average Cost of Capital (WACC) | 6.49% |
| Revenue Per Employee | $214,787 |
| Profits Per Employee | $21,349 |
| Employee Count | 7,500 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.27 |
Taxes
| Measure | Value |
|---|
| Income Tax | 51.59M |
| Effective Tax Rate | 24.37% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +5.96% |
| 50-Day Moving Average | 88.60 |
| 200-Day Moving Average | 76.94 |
| Relative Strength Index (RSI) | 41.27 |
| Average Volume (20 Days) | 729,947 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.79M |
| Short Previous Month | 3.63M |
| Short % of Shares Out | 6.33% |
| Short % of Float | 6.49% |
| Short Ratio (days to cover) | 6.23 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.61B |
| Gross Profit | 795.95M |
| Operating Income | 230.73M |
| Pretax Income | 211.71M |
| Net Income | 160.12M |
| EBITDA | 355.66M |
| EBIT | 230.73M |
| Earnings Per Share (EPS) | $2.67 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 503.55M |
| Total Debt | 822.06M |
| Net Cash | -318.51M |
| Net Cash Per Share | -$5.32 |
| Equity (Book Value) | 1.74B |
| Book Value Per Share | 29.13 |
| Working Capital | 933.73M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 273.74M |
| Capital Expenditures | -70.15M |
| Depreciation & Amortization | 124.92M |
| Net Borrowing | n/a |
| Free Cash Flow | 203.59M |
| FCF Per Share | $3.40 |
Margins
| Measure | Value |
|---|
| Gross Margin | 49.41% |
| Operating Margin | 14.32% |
| Pretax Margin | 13.14% |
| Profit Margin | 9.94% |
| EBITDA Margin | 22.08% |
| EBIT Margin | 14.32% |
| FCF Margin | 12.64% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.82% |
| Shareholder Yield | 0.82% |
| Earnings Yield | 3.10% |
| FCF Yield | 3.94% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $107.00 |
| Price Target Difference | 24.07% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 6.69% |
| EPS Growth Forecast (3Y) | 9.42% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 6, 2011 |
| Split Type | Forward |
| Split Ratio | 1.25:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.02 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |